Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

FONR vs DBVT vs ALKS vs AEYE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FONR
FONAR Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$124M
5Y Perf.-21.1%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-59.3%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+113.9%
AEYE
AudioEye, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$100M
5Y Perf.-7.2%

FONR vs DBVT vs ALKS vs AEYE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FONR logoFONR
DBVT logoDBVT
ALKS logoALKS
AEYE logoAEYE
IndustryMedical - DevicesBiotechnologyBiotechnologySoftware - Application
Market Cap$124M$1712.35T$5.90B$100M
Revenue (TTM)$106M$0.00$1.56B$40M
Net Income (TTM)$8M$-168M$153M$-3M
Gross Margin40.8%65.4%78.3%
Operating Margin10.1%12.3%-7.9%
Forward P/E15.3x24.8x
Total Debt$39M$22M$70M$721K
Cash & Equiv.$56M$194M$1.12B$5M

FONR vs DBVT vs ALKS vs AEYELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FONR
DBVT
ALKS
AEYE
StockMay 20May 26Return
FONAR Corporation (FONR)10078.9-21.1%
DBV Technologies S.… (DBVT)10040.7-59.3%
Alkermes plc (ALKS)100213.9+113.9%
AudioEye, Inc. (AEYE)10092.8-7.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: FONR vs DBVT vs ALKS vs AEYE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: FONR and ALKS are tied at the top with 2 categories each — the right choice depends on your priorities. Alkermes plc is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. DBVT and AEYE also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
FONR
FONAR Corporation
The Income Pick

FONR has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.10
  • Lower volatility, beta 0.10, Low D/E 24.3%, current ratio 8.45x
  • Beta 0.10, current ratio 8.45x
  • Better valuation composite
Best for: income & stability and sleep-well-at-night
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the clearest fit if your priority is momentum.

  • +110.4% vs AEYE's -27.9%
Best for: momentum
ALKS
Alkermes plc
The Quality Compounder

ALKS is the #2 pick in this set and the best alternative if quality and efficiency is your priority.

  • 9.8% margin vs AEYE's -7.6%
  • 5.4% ROA vs DBVT's -89.0%
Best for: quality and efficiency
AEYE
AudioEye, Inc.
The Growth Play

AEYE is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 14.5%, EPS growth 30.6%, 3Y rev CAGR 10.5%
  • 102.2% 10Y total return vs FONR's 35.0%
  • 14.5% revenue growth vs DBVT's -100.0%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthAEYE logoAEYE14.5% revenue growth vs DBVT's -100.0%
ValueFONR logoFONRBetter valuation composite
Quality / MarginsALKS logoALKS9.8% margin vs AEYE's -7.6%
Stability / SafetyFONR logoFONRBeta 0.10 vs AEYE's 2.29
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs AEYE's -27.9%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

FONR vs DBVT vs ALKS vs AEYE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FONRFONAR Corporation
FY 2025
Total
100.0%$104M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
AEYEAudioEye, Inc.
FY 2024
Enterprise
100.0%$15M

FONR vs DBVT vs ALKS vs AEYE — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLFONRLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 4 of 6 comparable metrics.

ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to AEYE's -7.6%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFONR logoFONRFONAR CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAEYE logoAEYEAudioEye, Inc.
RevenueTrailing 12 months$106M$0$1.6B$40M
EBITDAEarnings before interest/tax$15M-$112M$212M-$504,000
Net IncomeAfter-tax profit$8M-$168M$153M-$3M
Free Cash FlowCash after capex$6M-$151M$392M$2M
Gross MarginGross profit ÷ Revenue+40.8%+65.4%+78.3%
Operating MarginEBIT ÷ Revenue+10.1%+12.3%-7.9%
Net MarginNet income ÷ Revenue+7.1%+9.8%-7.6%
FCF MarginFCF ÷ Revenue+5.4%+25.1%+5.5%
Rev. Growth (YoY)Latest quarter vs prior year+2.4%+28.2%+7.9%
EPS Growth (YoY)Latest quarter vs prior year+6.9%+91.5%-4.1%+29.0%
ALKS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

FONR leads this category, winning 2 of 5 comparable metrics.

At 15.3x trailing earnings, FONR trades at a 38% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, FONR's 6.5x EV/EBITDA is more attractive than ALKS's 17.3x.

MetricFONR logoFONRFONAR CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAEYE logoAEYEAudioEye, Inc.
Market CapShares × price$124M$1712.35T$5.9B$100M
Enterprise ValueMkt cap + debt − cash$106M$1712.35T$4.9B$96M
Trailing P/EPrice ÷ TTM EPS15.35x-0.76x24.76x-32.36x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple6.52x17.25x
Price / SalesMarket cap ÷ Revenue1.19x4.00x2.49x
Price / BookPrice ÷ Book value/share0.77x0.66x3.28x20.91x
Price / FCFMarket cap ÷ FCF16.61x12.28x
FONR leads this category, winning 2 of 5 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 7 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to FONR's 0.24x. On the Piotroski fundamental quality scale (0–9), FONR scores 7/9 vs AEYE's 4/9, reflecting strong financial health.

MetricFONR logoFONRFONAR CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAEYE logoAEYEAudioEye, Inc.
ROE (TTM)Return on equity+4.3%-130.2%+8.8%-47.8%
ROA (TTM)Return on assets+3.5%-89.0%+5.4%-9.5%
ROICReturn on invested capital+6.1%+18.9%-42.4%
ROCEReturn on capital employed+5.9%-145.7%+14.2%-17.7%
Piotroski ScoreFundamental quality 0–97474
Debt / EquityFinancial leverage0.24x0.13x0.04x0.15x
Net DebtTotal debt minus cash-$17M-$172M-$1.0B-$5M
Cash & Equiv.Liquid assets$56M$194M$1.1B$5M
Total DebtShort + long-term debt$39M$22M$70M$721,000
Interest CoverageEBIT ÷ Interest expense705.24x-189.82x32.30x-2.79x
ALKS leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AEYE leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs AEYE's -27.9%. The 3-year compound annual growth rate (CAGR) favors AEYE at 6.4% vs FONR's 4.6% — a key indicator of consistent wealth creation.

MetricFONR logoFONRFONAR CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAEYE logoAEYEAudioEye, Inc.
YTD ReturnYear-to-date+1.9%+4.9%+25.3%-18.7%
1-Year ReturnPast 12 months+53.4%+110.4%+16.5%-27.9%
3-Year ReturnCumulative with dividends+14.3%+19.7%+14.5%+20.6%
5-Year ReturnCumulative with dividends+9.8%-69.1%+60.9%-60.2%
10-Year ReturnCumulative with dividends+35.0%-87.0%-11.0%+102.2%
CAGR (3Y)Annualised 3-year return+4.6%+6.2%+4.6%+6.4%
AEYE leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

FONR leads this category, winning 2 of 2 comparable metrics.

FONR is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than AEYE's 2.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FONR currently trades 99.6% from its 52-week high vs AEYE's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFONR logoFONRFONAR CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAEYE logoAEYEAudioEye, Inc.
Beta (5Y)Sensitivity to S&P 5000.09x1.26x1.00x2.18x
52-Week HighHighest price in past year$18.95$26.18$36.60$16.39
52-Week LowLowest price in past year$12.17$7.53$25.17$5.31
% of 52W HighCurrent price vs 52-week peak+99.6%+76.3%+96.7%+49.4%
RSI (14)Momentum oscillator 0–10067.748.160.261.3
Avg Volume (50D)Average daily shares traded52K252K2.3M194K
FONR leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

AEYE leads this category, winning 1 of 1 comparable metric.

Analyst consensus: DBVT as "Buy", ALKS as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 29.9% for ALKS (target: $46).

MetricFONR logoFONRFONAR CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAEYE logoAEYEAudioEye, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$46.33$46.00
# AnalystsCovering analysts1528
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0001
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+1.5%0.0%+0.5%0.0%
AEYE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FONR leads in 2 (Valuation Metrics, Risk & Volatility).

Best OverallFONAR Corporation (FONR)Leads 2 of 6 categories
Loading custom metrics...

FONR vs DBVT vs ALKS vs AEYE: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is FONR or DBVT or ALKS or AEYE a better buy right now?

For growth investors, AudioEye, Inc.

(AEYE) is the stronger pick with 14. 5% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). FONAR Corporation (FONR) offers the better valuation at 15. 3x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FONR or DBVT or ALKS or AEYE?

On trailing P/E, FONAR Corporation (FONR) is the cheapest at 15.

3x versus Alkermes plc at 24. 8x.

03

Which is the better long-term investment — FONR or DBVT or ALKS or AEYE?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: AEYE returned +96. 5% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FONR or DBVT or ALKS or AEYE?

By beta (market sensitivity over 5 years), FONAR Corporation (FONR) is the lower-risk stock at 0.

09β versus AudioEye, Inc. 's 2. 18β — meaning AEYE is approximately 2451% more volatile than FONR relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 24% for FONAR Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — FONR or DBVT or ALKS or AEYE?

By revenue growth (latest reported year), AudioEye, Inc.

(AEYE) is pulling ahead at 14. 5% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: AudioEye, Inc. grew EPS 30. 6% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, AEYE leads at 10. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FONR or DBVT or ALKS or AEYE?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -7. 6% for AudioEye, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -7. 9% for AEYE. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — FONR or DBVT or ALKS or AEYE?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is FONR or DBVT or ALKS or AEYE better for a retirement portfolio?

For long-horizon retirement investors, FONAR Corporation (FONR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

09)). AudioEye, Inc. (AEYE) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FONR: +34. 7%, AEYE: +96. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between FONR and DBVT and ALKS and AEYE?

These companies operate in different sectors (FONR (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and AEYE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FONR is a small-cap deep-value stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; AEYE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

FONR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

AEYE

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 46%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.